HomeCYTOF • OTCMKTS
add
Altamira Therapeutics Ltd
Previous close
$0.051
Day range
$0.061 - $0.10
Year range
$0.050 - $0.85
Market cap
519.28K USD
Avg Volume
8.59K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.31M | -32.89% |
Net income | -767.51K | 64.63% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.31M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.76K | -94.26% |
Total assets | 7.13M | -11.64% |
Total liabilities | 3.06M | 74.56% |
Total equity | 4.07M | — |
Shares outstanding | 5.72M | — |
Price to book | 0.07 | — |
Return on assets | -46.09% | — |
Return on capital | -67.56% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -767.51K | 64.63% |
Cash from operations | -692.07K | 56.80% |
Cash from investing | -231.00 | -174.52% |
Cash from financing | 183.97K | -85.37% |
Net change in cash | -504.73K | -51.06% |
Free cash flow | -663.71K | 37.89% |
About
Founded
2003
Headquarters
Website
Employees
11
